Christopher J. Calamari - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship
SENIOR VICE PRESIDENT
Issuer ticker
ABT
Reported as of
28 Feb 2023
Net transaction value
-$282,050
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2023, 18:22:08 UTC
Prior SEC filing
22 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher J. Calamari by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Christopher J. Calamari filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2023.

Key facts

  • This page summarizes Christopher J. Calamari's Form 4 filing for ABBOTT LABORATORIES (ABT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2023, 18:22.

Change

  • Previous filing in this sequence was filed on 22 Feb 2023.
  • Current net transaction value: -$282,050.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value
$282,050
Shares
-2,827
Change %
-7.9%
Price
$99.77
Shares after
32,822
Date
28 Feb 2023
Ownership
Direct
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,193
Date
28 Feb 2023
Ownership
The Calamari Family Trust
ABT holding

Common shares without par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
103
Date
28 Feb 2023
Ownership
Profit Sharing Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .